20
Participants
Start Date
November 30, 2005
Primary Completion Date
February 29, 2008
Study Completion Date
February 29, 2008
atomoxetine
This study utilizes a crossover design. Accordingly, half of the participants receive 40 milligram twice a day atomoxetine at arm one while the remaining half receive this intervention at arm two.
Matching Placebo
This study utilizes a crossover design. Accordingly, half of the participants receive twice a day matching placebo at arm one while the remaining half receive this intervention at arm two.
The University of Iowa, Iowa City
Eli Lilly and Company
INDUSTRY
University of Iowa
OTHER